Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TGFBR1 | P36897 | 1/20 | 0.34 |
| ▸ | ANPEP | P15144 | 2/20 | 0.32 |
| ▸ | RNPEP | Q9H4A4 | 2/20 | 0.32 |
| ▸ | DNPEP | Q9ULA0 | 1/20 | 0.32 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.31 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.31 |
| ▸ | GAA | P10253 | 1/20 | 0.30 |
| ▸ | RAB9A | P51151 | 1/20 | 0.30 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7757017 | 0.83 | TGFBR1 (0.35) | TGFBR1ANPEPRNPEPDNPEPGAA | |
| SCHEMBL18141154 | 0.83 | TGFBR1 (0.43) | TGFBR1ANPEPRNPEPDNPEPGAA | |
| SCHEMBL9818639 | 0.81 | TGFBR1 (0.36) | TGFBR1 | |
| SCHEMBL98539 | 0.80 | TGFBR1 (0.38) | TGFBR1ANPEPRNPEPDNPEPGAA | |
| Ammonia Solution, Strong SCHEMBL28096709 | 0.79 | TGFBR1 (0.37) | TGFBR1ANPEPRNPEPDNPEPGAA | |
| SCHEMBL157717 | 0.79 | ALDH1A1 (0.45) | TGFBR1ANPEPRNPEPDNPEPGAA | |
| SCHEMBL3235398 | 0.76 | ANPEP (0.52) | TGFBR1ANPEPRNPEPDNPEPHSD17B10 | |
| SCHEMBL9771629 | 0.76 | — | — | |
| SCHEMBL316224 | 0.75 | TGFBR1 (0.41) | TGFBR1HSD17B10TDP1RAB9ASMN1; SMN2 | |
| SCHEMBL7129431 | 0.75 | ANPEP (0.42) | TGFBR1ANPEPRNPEPDNPEPTDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7579485-B2 | Process for producing lactone | MITSUBISHI RAYON CO., LTD. (JP) | 2009-08-25 | — | — | US | disclosed |
| EP-1473291-B1 | PROCESS FOR PRODUCING LACTONE | MITSUBISHI RAYON CO (JP) | 2008-08-13 | — | — | EP | disclosed |
| US-20050080276-A1 | Process for producing lactone | MITSUBISHI CHEMICAL CORPORATION (JP) | 2005-04-14 | — | — | US | disclosed |
| EP-1473291-A1 | PROCESS FOR PRODUCING LACTONE | Mitsubishi Rayon Co., Ltd. (JP) | 2004-11-03 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050080276-A1 | Process for producing lactone | DCXR, MRPL21, LSS | TGFBR1 2749/4885ANPEP 2464/4885RNPEP 2309/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.